Qianmiao Peptide
Tirzepatide
Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Qianmiao Peptide between 20 Feb 2026 and 29 Mar 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Qianmiao Peptide
Tirzepatide
Tested 4 Samples
Last test 29 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Qianmiao Peptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
29 Mar 2026
First
20 Feb 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 29 Mar 2026 | View | 50mg | 47.5mg | -5.0% | 99.80% | 1/21/2026 | No Label / Silver Crimp / Yellow Cap | Lab G | Public | |
| 2 Mar 2026 | View | 30mg | 24.1mg | -19.7% | 99.90% | January 23,2026 | No Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 2 Mar 2026 | View | 20mg | 22.3mg | +11.5% | 99.90% | Jan 2,2026 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 20 Feb 2026 | View | 60mg | 64mg | +6.7% | 99.90% | FE T60 DEC 2 2025 | White Label / Silver Crimp / Orange Cap | Lab E | Public | |